About us-TriApex

Build a world-famous and domestic
advanced CRO that enables
the disease-oriented R&D.

group profile

Provide global pharmaceutical enterprises and research institutions with new drug R&D in disease-oriented fields

TriApex Laboratories Co., Ltd. (TriApex), founded in 2008, is an innovative CRO dedicated to providing integrated solutions and enabling the specialized disease-oriented R&D for global pharmaceutical enterprises and research institutions.

TriApex takes concentrating on scientific assessment, enabling translational research, and improving quality of life as its own mission. Relying on the top technical service team in the industry, building and improving group management, TriApex focuses on the pathogenesis and models of diseases, nonclinical research, and clinical and translational research by means of highly scientific and professional operation strategies.

TriApex, taking advantage of its excellent service quality and abundant industry experience, powers innovation of technologies, leads industry innovation, and consistently forges ahead on the road to promoting human health development.

Technical Team

40

+

Doctors

150

+

Masters

7

Toxicologists

8

DACVPs

5

CSQAs

Vision

Innovative CRO enabling new drug R&D in disease-oriented fields

Missions

Dedicated to scientific assessment, enabling transformation of innovation, and improving quality of life

Values

Integrity Dedication Cooperation Excellence

Partners

TriApex owns 500+ outstanding partners in the world, and this number is still rapidly increasing.

In deep participation in various projects, TriApex, relying on increasing experiences and accumulative methods, continues to enable disease-oriented R&D and has unique advantages in promoting its own and the industry's innovative transformation.

500 +

domestic/overseas outstanding partners

TOP20

Deep cooperation with TOP20 global pharmaceutical enterprises

200 +

Experience in cooperation with 200+ national clinical research centers

Members of TriApex

TriApex Nanjing

Industry-leading CRO providing one-stop solutions

TriApex, founded in 2008, is a contract research organization (CRO) providing pharmaceutical R&D services. We are dedicated to providing nonclinical services including pharmacokinetics studies, safety assessment and biological sample analysis of traditional Chinese medicine, chemical and biotech drugs for domestic and global pharmaceutical R&D institutions, which comply with submission requirements for international application (NMPA/FDA).

Learn more

Kunming Biomed (KBI)

TriApex Biotechnology

History

2008

founded in 2008.

2011

certificated by CFDA for conduct of GLP studies.

2012

accredited by AAALAC.

2016

conducted non-clinical studies supporting for CFDA/FDA submission.

2018

TriApex(Nanjing) Clinical Medicine was founded

TriApexPharmaceutical Research Launches OECD Qualification Certification/SEND System Online

2019

Shanghai TriApex Biotechnology Co., Ltd. was founded

TriApex passed the re-inspection by NMPA.

2020

Harborside

TriApex (Shanghai) in operation

TriApex Med Chengdu Beauty Medical (dedicated to ophthalmology) was founded.

2021

TriApex achieved group management

acquisition of Kunming KBI.

2022

a laboratory animal resource platform was founded/ layout of disease-oriented R&D (Ophthalmology/CNS/Metabolic Disease) was deepened /international business development was strengthened.

2023

Bulit US business team

Launched experimental animal resource platform

Had been focusing on specialized disease-oriented R&D(Ophthalmology / CNS / Metabolism)

2024

Established US analytical laborator

Internationalization development

2008

2011

2012

2016

2018

2019

2020

2021

2022

2023

2024

Global Layout

Nanjing

Shanghai

Kunming

Hainan

Boston

Chengdu

Nanjing

NanJing

TriApex Nanjing

Non-clinical GLP Laboratory facilities

Phase I Approximately 16, 000㎡

Phase II Approximately 23, 400㎡

Accelerator Approximately 5, 200 ㎡

TriApex Medicine

Abundant Clinical Research Resources

Experience in organizing 500+ registration communication conferences

Experience in successfully enabling 200+ listed projects

Experience in compiling management manual of research center

Experience in team management of clinical operation teams with 700 people

Experience in completed recruitment of 5000 subjects

Jiangsu Yadong Experimental Animal Research Institute

Laboratory animal resource bases

Shanghai

ShangHai

TriApex Biotechnology

Clinical biological sample analysis&medicine inspection laboratory

Approximately 3,000㎡in Cambridge&approximately 4,000㎡ in South Bridge

Harborside

Nonclinical Medical Device Laboratories

Over 3, 000㎡of Phase I fresh air system laboratory platform

4, 000㎡of Phase II expansion

Kunming

KunMing

Kunming KBI

NHP Laboratory base

Approximately 120,000㎡

Hainan

HaiNan

NHP Laboratories

Boston

Boston

R&D center

Chengdu

ChengDu

Beauty Medical Technology

Clinical research base for ophthalmic drugs and products